Welcome to Dual Diagnosis and Addiction Treatment

Home > GAD > World of People

GENERALIZED ANXIETY DISORDER

Generalized anxiety disorder (GAD) is much more intense than the normal anxiety people experience on a day to day basis. This anxiety is chronic and fills one's everyday life with worry and tension, even when there wasn't anything really to provoke it. An individual with this disorder constantly worries excessively about everything from income, to friends and family, or employment. GAD is perhaps better characterized by the anticipation of disaster that usually is present in every moment of the afflicted individual's day. A rudimentary event like getting through the day is enough to provoke anxiety. People experiencing this anxiety, though they know it is irrational, cannot usually shake their fears.

	Quick Facts			People with GAD

	Symptoms			Treatment

	Research

Onset of GAD varies between beginning in childhood and middle age. Unlike people with other anxiety disorders, people with GAD don't characteristically avoid certain situations as a result of their disorder. When impairment associated with GAD is mild, people with the disorder may be able to function in social settings or on the job. If severe, however, GAD can be very debilitating, making it difficult to carry out even the most ordinary daily activities. An individual with GAD has usually been diagnosed with another disorder, either related to anxiety, a mental disorder or related to substance abuse.

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo ...

MediciNova to Present at the Rodman and Renshaw Annual Global Investment Conf...

SAN DIEGO -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange , today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the Rodman and Renshaw Annual Global Investment Conference on Monday, September 13, 2010 at 3:40 p.m.

Home